Next Sequence

Next Sequence is a New York-based venture capital firm founded in 2021 that invests in pre-seed and seed-stage startups merging. See contact routes.

About Next Sequence

Next Sequence is a New York-based venture capital firm founded in 2021 that invests in pre-seed and seed-stage startups merging artificial intelligence with synthetic biology (TechBio). The firm targets check sizes of $50,000 to $100,000 and operates a distinctive 6–12 month AI accelerator program, "Next.AI," designed to transform biotech startups into SaaS-like companies by leveraging computing to accelerate R&D. Notable portfolio companies include Biomemory, Cradle, and ArgenTAG, reflecting their thesis of using AI and quantum computing to address challenges like pandemics, aging, and climate change.

Next Sequence at a glance

Role
Managing Director
Location
New York, New York, United States
Investor type
Venture Capital

Frequently asked about Next Sequence

What does Next Sequence invest in?
We have not verified a stated sector or stage focus for Next Sequence (New York, New York, United States). The profile lists the organization, location and investors we track alongside them.
How do I contact Next Sequence?
Next Sequence's published profile links (website, LinkedIn or X where available) are listed on the StartupFundraising.com investor profile.
Where is Next Sequence headquartered?
Next Sequence is based in New York, New York, United States.

Details on this firm come from filing and round data held in the StartupFundraising directory, refreshed on ingest. Founders use profiles like this one to qualify fit and to shortlist investors in New York.

Investors similar to Next Sequence (20)

Browse related investor lists (2)

Compare Next Sequence (8)

Investors like Next Sequence · Full investor directory · Investor access · Company funding database